Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66870-1-Ig - Provider product page

- Provider
- Proteintech Group
- Product name
- KPNA2 antibody
- Antibody type
- Monoclonal
- Description
- KPNA2 antibody (Cat. #66870-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 2G9C1
- Vial size
- 20ul, 150ul
Submitted references YWHAZ downregulated innate immune responses to RNA viruses by inhibiting the IRF3 signaling pathway.
KPNA2 silencing sensitizes triple-negative breast cancer to chemotherapy by promoting multipolar division and suppressing DNA damage repair.
Palmitoylated importin α regulates mitotic spindle orientation through interaction with NuMA.
Study on the molecular mechanism of KPNA2 regulation of myocardial ischemia/delayed reperfusion injury through mitophagy.
Li S, Han J, Wang H, Hou J, Wang L, Hou Z, Zhang Y, Dou X, Xie J, Li H, Li X, Feng R
mSphere 2026 Apr 28;11(4):e0003826
mSphere 2026 Apr 28;11(4):e0003826
KPNA2 silencing sensitizes triple-negative breast cancer to chemotherapy by promoting multipolar division and suppressing DNA damage repair.
Cai Y, Du J, Wang H, Shen L, Xu Z, Zhaoxiong Y, Gong Z, Zhu Y, Wu C, Cai J, Zhang P, Chen S, Dai Z, Huang R, Zhu W
Oncogene 2025 Nov;44(44):4254-4270
Oncogene 2025 Nov;44(44):4254-4270
Palmitoylated importin α regulates mitotic spindle orientation through interaction with NuMA.
Sutton PJ, Mosqueda N, Brownlee CW
EMBO reports 2025 Jul;26(13):3280-3304
EMBO reports 2025 Jul;26(13):3280-3304
Study on the molecular mechanism of KPNA2 regulation of myocardial ischemia/delayed reperfusion injury through mitophagy.
Tao E, Tao Z, Wang F, Bai S, Lai S, Li X, Bai Y, Peng C, Wan L
Cellular signalling 2025 Dec;136:112157
Cellular signalling 2025 Dec;136:112157
No comments: Submit comment
No validations: Submit validation data